Evidence for a glycine residue at position 316 in human protein C inhibitorMEIJERS, J. C. M; CHUNG, D. W.Thrombosis research. 1990, Vol 59, Num 2, pp 389-393, issn 0049-3848, 5 p.Article

Organization of the gene coding for human protein C inhibitor (plasminogen activator inhibitor-3) : assignment of the gene to chromosome 14MEIJERS, J. C. M; CHUNG, D. W.The Journal of biological chemistry (Print). 1991, Vol 266, Num 23, pp 15028-15034, issn 0021-9258Article

Platelet-vessel wall interaction in health and diseaseLÖWENBERG, E. C; MEIJERS, J. C. M; LEVI, M et al.Netherlands journal of medicine. 2010, Vol 68, Num 6, pp 242-251, issn 0300-2977, 10 p.Article

Fibrinolysis and the contact system : A role for factor XI in the down-regulation of fibrinolysisBOUMA, B. N; MEIJERS, J. C. M.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 243-250, issn 0340-6245Article

Expression of human blood coagulation factor. XI: Characterization of the defect in factor XI type III deficiencyMEIJERS, J. C. M; DAVIES, E. W; CHUNG, D. W et al.Blood. 1992, Vol 79, Num 6, pp 1435-1440, issn 0006-4971Article

A (CA)_n repeat polymorphism in the protein C inhibitor (PCI) geneBYTH, B. C; MEIJERS, J. C. M; COX, D. W et al.Human molecular genetics (Print). 1993, Vol 2, Num 10, issn 0964-6906, p. 1752Article

Review: Viral Infections and Mechanisms of Thrombosis and BleedingGOEIJENBIER, M; WISSEN, M. Van; DE WEG, C. Van et al.Journal of medical virology. 2012, Vol 84, Num 10, pp 1680-1696, issn 0146-6615, 17 p.Article

Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutationKEMMEREN, J. M; ALGRA, A; MEIJERS, J. C. M et al.Thrombosis and haemostasis. 2002, Vol 87, Num 2, pp 199-205, issn 0340-6245, 7 p.Article

Factor XI dependent and independent activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in plasma associated with clot formationBOUMA, B. N; MOSNIER, L. O; MEIJERS, J. C. M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 6, pp 1703-1708, issn 0340-6245Article

Factor XI activation by meizothrombin : Stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamineVON DEM BORNE, P. A. K; MOSNIER, L. O; TANS, G et al.Thrombosis and haemostasis. 1997, Vol 78, Num 2, pp 834-839, issn 0340-6245Article

Kinetics of factor VIII-von Willebrand factor associationVLOT, A. J; KOPPELMAN, S. J; MEIJERS, J. C. M et al.Blood. 1996, Vol 87, Num 5, pp 1809-1816, issn 0006-4971Article

Role of the A⁺ helix in heparin binding to protein C inhibitorELISEN, M. G. L. M; MASELAND, M. H. H; CHURCH, F. C et al.Thrombosis and haemostasis. 1996, Vol 75, Num 5, pp 760-766, issn 0340-6245Article

Apple four in human blood coagulation factor XI mediates dimer formationMEIJERS, J. C. M; MULVIHILL, E. R; DAVIE, E. W et al.Biochemistry (Easton). 1992, Vol 31, Num 19, pp 4680-46847, issn 0006-2960Article

Protein C and S and inflammation in sickle cell diseaseSCHNOG, J. B; MAC GILLAVRY, M. R; VAN ZANTEN, A. P et al.American journal of hematology. 2004, Vol 76, Num 1, pp 26-32, issn 0361-8609, 7 p.Article

Potential role of platelets in endothelial damage observed During treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416KUENEN, B. C; LEVI, M; MEIJERS, J. C. M et al.Journal of clinical oncology. 2003, Vol 21, Num 11, pp 2192-2198, issn 0732-183X, 7 p.Article

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell diseaseSCHNOG, J. B; MACGILLAVRY, M. R; ROJER, R. A et al.American journal of hematology. 2002, Vol 71, Num 1, pp 53-55, issn 0361-8609Article

Characterization of transgenic mice that secrete functional human protein C inhibitor into the circulationWAGENAAR, G. T. M; HANNEKE VAN VUUREN, A. J; GIRMA, M et al.Thrombosis and haemostasis. 2000, Vol 83, Num 1, pp 93-101, issn 0340-6245Article

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives : a cross-over studyMIDDELDORP, S; MEIJERS, J. C. M; VAN DEN ENDE, A. E et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 4-8, issn 0340-6245Article

The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein SVAN WIJNEN, M; STAM, J. G; VAN'T VEER, C et al.Thrombosis and haemostasis. 1996, Vol 76, Num 3, pp 397-403, issn 0340-6245Article

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysisVON DEM BORNE, P. A. K; MEIJERS, J. C. M; BOUMA, B. N et al.Blood. 1995, Vol 86, Num 8, pp 3035-3042, issn 0006-4971Article

Inactivation of human factor VIII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factorKOEDAM, J. A; MEIJERS, J. C. M; SIXMA, J. J et al.The Journal of clinical investigation. 1988, Vol 82, Num 4, pp 1236-1243, issn 0021-9738Article

Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutationKEMMEREN, J. M; ALGRA, A; MEIJERS, J. C. M et al.Blood coagulation & fibrinolysis. 2002, Vol 13, Num 5, pp 373-381, issn 0957-5235Article

Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: A randomized cross-over study of two low-dose oral contraceptivesMEIJERS, J. C. M; MIDDELDORP, S; TEKELENBURG, W et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 9-14, issn 0340-6245Article

New concepts in activation of the clotting cascade in sepsisMEIJERS, J. C. M; BOUMA, B. N.Sepsis (Boston). 1999, Vol 3, Num 2, pp 87-91, issn 1385-0229Article

Low-dose oral contraceptives and acquired resistance to activated protein C : a randomised cross-over studyROSING, J; MIDDELDORP, S; CURVERS, J et al.Lancet (British edition). 1999, Vol 354, Num 9195, pp 2036-2040, issn 0140-6736Article